In addition, thanks to the combination of telemonitoring and teleintervention, a 70% reduction in episodes of decompensation is also achieved.

The prestigious scientific journal The Lancet Digital Health has published these results from a pioneering clinical trial on mHealth (mobile health), led by Bellvitge University Hospital, IDIBELL, and CIBERCV.

Patients under follow-up at Bellvitge University Hospital, Viladecans Hospital, and Delta Primary Care (Metropolitan South area) are already benefiting from the knowledge generated by this research, with plans to soon scale it up to other hospitals and regions.

This surgery enables the removal of complex tumors with significant venous involvement by using a temporary blood flow diversion technique. The procedure was made possible thanks to the prior creation of a three-dimensional model for advanced surgical planning.

The Bellvitge University Hospital has become the first public hospital in Spain—and one of the first centres in Europe—to test the new TouMai surgical robot, developed in China by the company MicroPort MedBot. The system, which already has CE marking, was installed at the hospital for a week as part of its commitment to innovation and cutting-edge robotic surgery.

The University of Barcelona has recognized the contribution of the CardioSimHub Chair, promoted by the Bellvitge Hospital and various industrial partners, as a model of innovation and knowledge transfer in cardiovascular health.

The multidisciplinary team from the Functional Unit of Transgender Surgery at Bellvitge University Hospital has celebrated the completion of its first 100 vaginoplasties. This milestone confirms the unit's expertise and establishes it as one of the leading centres in Catalonia for sex reassignment surgery.

It reached a peak of 542 COVID patients hospitalized at the same time, 186 of whom were in critical and semi-critical care beds.

A large-scale reorganization of tasks was designed, creating new teams capable of responding to the extremely high demand.